PMS: Diagnosis, aetiology, assessment and management revisiting

Advances in Psychiatric Treatment

Volumn 13, Issue 2, 2007, Pages 139-146

  Henshaw, Carol A ^a  

^a KEELE UNIVERSITY SCHOOL OF MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BUSPIRONE; CITALOPRAM; DANAZOL; DROSPIRENONE PLUS ETHINYLESTRADIOL; FLUOXETINE; GONADORELIN; ORAL CONTRACEPTIVE AGENT; PRIMROSE OIL; SEROTONIN UPTAKE INHIBITOR; VENLAFAXINE;

ANXIETY DISORDER; BEHAVIOR THERAPY; BLOATING; CLINICAL TRIAL; COGNITIVE THERAPY; COMORBIDITY; CULTURAL ANTHROPOLOGY; DEPRESSION; DISEASE COURSE; DRUG EFFICACY; DRUG WITHDRAWAL; DYSTHYMIA; ENDOCRINE DISEASE; EXERCISE; FEMALE; GABAERGIC SYSTEM; HEADACHE; HERBAL MEDICINE; HORMONE SUBSTITUTION; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; IRRITABILITY; MASTALGIA; MOOD DISORDER; PATHOPHYSIOLOGY; PERCEPTION; PREMENSTRUAL DYSPHORIC DISORDER; PREMENSTRUAL SYNDROME; REVIEW; SELF HELP; SEROTONINERGIC SYSTEM; SOCIAL ASPECT; SOCIAL PSYCHIATRY; SOMATOFORM DISORDER; VITAMIN SUPPLEMENTATION;

EID: 38549105641     PISSN: 13555146     EISSN: None     Source Type: Journal    
DOI: 10.1192/apt.bp.106.003392     Document Type: Review

References (45)

1. Atmaca, M., Kumru, S. & Tezcan, E. (2003) Fluoxetine versus Vitex agnus castus extract in the treatment of premenstrual dysphoric disorder. Human Psychopharmacology, 18, 191-195.
2. Blake, F., Salkovskis, P., Gath, D., et al (1998) Cognitive therapy for premenstrual syndrome. A controlled trial. Journal of Psychosomatic Research, 45, 307-318.
3. Budeiri, D., Li Wan Po, A. & Doman, J. C. (1996) Is evening primrose oil of value in the treatment of premenstrual syndrome? Controlled Clinical Trials, 17, 60-68.
4. Chrisler, J. C. & Caplan, P. (2002) The strange case of Dr. Jekyll and Ms. Hyde: how PMS became a cultural phenomenon and a psychiatric disorder. Annual Review of Sex Research, 13, 274-306.
5. Christensen, A. P. & Oei, T. P. S. (1995) The efficacy of cognitive behaviour therapy in treating premenstrual dysphoric changes. Journal of Affective Disorders, 33, 57-63.
6. Cohen, L. S., Soares, C. N., Otto, M. W., et al (2002) Prevalence and predictors of premenstrual dysphoric disorder (PMDD) in older premenopausal women. The Harvard Study of Moods and Cycles. Journal of Affective Disorders, 70, 125-132.
7. Connolly, M. (2001) Premenstrual syndrome: an update on definitions, diagnosis and management. Advances in Psychiatric Treatment, 7, 469-476.
8. Dimmock, P. W., Wyatt, K. M., Jones, P. W., et al (2000) Efficacy of selective serotonin-reuptake inhibitors in premenstrual syndrome: a systematic review. Lancet, 356, 1131-1136.
9. Epperson, C. N., Haga, K., Mason, G. F., et al (2002) Cortical gamma-aminobutyric acid levels across the menstrual cycle in healthy women and those with premenstrual dysphoric disorder: a proton magnetic resonance spectroscopy study. Archives of General Psychiatry, 59, 851-858.
10. Freeman, E. W., Rickels, K., Yonkers, K. A., et al (2001) Venlafaxine in the treatment of premenstrual dysphoric disorder. Obstetrics and Gynecology, 98, 737-744.
11. Freeman, E. W., Frye, C. A., Rickels, K., et al (2002 a) Allopregnanolone levels and symptom improvement in severe premenstrual syndrome. Journal of Clinical Psychopharmacology, 22, 516-520.
12. Freeman, E. W., Jabara, S., Sondheimer, S. J., et al (2002 b) Citalopram in PMS patients with prior SSRI treatment failure: a preliminary study. Journal of Womens Health and Gender-Based Medicine, 11, 459-464.
13. Freeman, E. W., Rickels, K., Sondheimer, S. J., et al (2004) Continuous or intermittent dosing with sertraline for patients with severe premenstrual syndrome or premenstrual dysphoric disorder. American Journal of Psychiatry, 161, 343-351.
14. Girman, A., Lee, R. & Kligler, B. (2003) An integrative medicine approach to premenstrual syndrome. American Journal of Obstetrics and Gynecology, 188, s56-s65.
15. Halbreich, U. (2003) The etiology, biology, and evolving pathology of premenstrual syndromes. Psychoneuroendocrinology, 28, s1-s99.
16. Halbreich, U. (2005) Algorithm for treatment of premenstrual syndrome (PMD). Experts' recommendations and limitations. Gynecological Endocrinology, 20, 48-56.
17. Haywood, A., Slade, P. & King, H (2002) Assessing the assessment measures for menstrual cycle symptoms: a guide for researchers and clinicians. Journal of Psychosomatic Research, 52, 223-237.
18. Hunter, M. S., Ussher, J. M., Browne, S. J., et al (2002) A randomized comparison of psychological (cognitive behavior therapy), medical (fluoxetine) and combined treatment for women with premenstrual dysphoric disorder. Journal of Psychosomatic Obstetrics and Gynecology, 23, 193-199.
19. Hylan, T. R., Sundell, K. & Judge, R. (1999) The impact of premenstrual symptomatology on functioning and treatment-seeking behavior: experience from the United States, United Kingdom, and France. Journal of Women's Health and Gender-Based Medicine, 8, 1043-1052.
20. Kim, D.R., Gyulai, E.W., Freeman, E. W et al (2004) Premenstrual dysphoric disorder and psychiatric co-morbidity. Archives of Womens' Mental Health, 7, 37-47.
21. Krasnik, C., Montori, V. M, Guyatt, G.H et al (2005) The effect of bright light therapy on depression associated with premenstrual dysphoric disorder. American Journal of Obstetrics and Gynecology, 193, 658-661.
22. Landen, M., Eriksson, O., Sundblad, C., et al (2001) Compounds with affinity for serotonergic receptors in the treatment of premenstrual dysphoria: a comparison of buspirone, nefazodone and placebo. Psychopharmacology, 155, 292-298.
23. Marvan, M. L., Diaz-Erosa, M. & Montesinos, A. (1998) Premenstrual symptoms in Mexican women with different educational levels. Journal of Psychology, 132, 517-526.
24. Miner, C., Brown, E., McCray, S., et al (2002) Weekly luteal-phase dosing with enteric-coated fluoxetine 90mg in premenstrual dysphoric disorder: a randomized, double-blind, placebo-controlled clinical trial. Clinical Therapeutics, 24, 417-433.
25. Moynihan, R. (2004) Controversial disease dropped from Prozac product information. BMJ, 328, 365. doi:10.1136/bmj.328.7436.365.
26. Pearlstein, T. B., Halbreich, U., Batzar, E. D., et al (2000) Psychosocial functioning in women with premenstrual dysphoric disorder before and after treatment with sertraline or placebo. Journal of Clinical Psychiatry, 61, 101-109.
27. Raitt, F. E. & Zeedyk, M. S. (2002) The Implicit Relation of Psychology and Law: Women and Syndrome Evidence. Routledge.
28. Rasheed, P. & Al-Sowielem, L. S. (2003) Prevalence and predictors of premenstrual syndrome among college-aged women in Saudi Arabia. Annals of Saudi Medicine, 23, 381-387.
29. Roca, C. A., Schmidt, P, J., Smith, M. J., et al (2002) Effects of metergoline on symptoms in women with premenstrual dysphoric disorder. American Journal of Psychiatry, 159, 1876-1881.
30. Smith, M. J., Adams, L. F., Schmidt, P. J., et al (2003) Abnormal luteal phase excitability of the motor cortex in women with premenstrual syndrome. Biological Psychiatry, 54, 757-762.
31. Steiner, M., Lamont, J., Steinberg, S., et al (1997) Effect of fluoxetine on menstrual cycle length in women with premenstrual dysphoria. Obstetrics and Gynecology, 90, 590-595.
32. Steiner, M., Pearlstein, T., Cohen, L. S., et al (2006) Expert guidelines for the treatment of severe PMS, PMDD and comorbidities: the role of SSRIs. Journal of Women's Health, 15, 57-69.
33. Stevinson, C. & Ernst, E. (2001) Complementary/alternative therapies for premenstrual syndrome: a systematic review of randomized controlled trials. American Journal of Obstetrics and Gynecology, 185, 227-235.
34. Straneva, P. A., Maixner, W., Light, K. C., et al (2002) Menstrual cycle, beta-endorphins, and pain sensitivity in premenstrual dysphoric disorder. Health Psychology, 21, 358-367.
35. Sundström Poromaa, I., Smith, S. & Gulinello, M. (2003) GABA receptors, progesterone and premenstrual dysphoric disorder. Archives of Women's Mental Health, 6, 23-41.
36. Sveinsdottir, H. & Marteinsdottir, G. (1991) Retrospective assessment of premenstrual changes in Icelandic women. Health Care for Women International, 12, 303-315.
37. Sveinsdóttir, H., Lundman, B. & Norbeg, A. (2002) Whose voice? Whose experiences? Women's qualitative accounts of general and private discussion of premenstrual syndrome. Scandinavian Journal of Caring Sciences, 16, 414-423.
38. Swann, C. J. & Ussher, J. M. (1995) A discourse analytic approach to women's experience of premenstrual syndrome. Journal of Mental Health, 4, 359-367.
39. Takeda, T., Tasaka, K., Sakata, M., et al (2006) Prevalence of premenstrual syndrome and premenstrual dysphoric disorder in Japanese women. Archives of Women's Mental Health, 9, 209-212.
40. Winther, K. & Hedman, C. (2002) Assessment of the effects of the herbal remedy femal on the symptoms of premenstrual syndrome: a randomized, double-blind, placebo-controlled study. Current Therapeutic Research, 63, 344-353.
41. Wittchen, H. U., Becker, E., Lieb, R., et al (2002) Prevalence, incidence and stability of premenstrual dysphoric disorder in the community. Psychological Medicine, 32, 119-132.
42. Wyatt, K., Dimmock, R, Jones, R, et al (2001) Efficacy of progesterone and progestogens in the management of premenstrual syndrome: systematic review. BMJ, 323, 776-780.
43. Wyatt, K. M., Dimmock, P. W., Ismail, K. M. K., et al (2004) The effectiveness of GnRHa with and without 'add-back' therapy in treating premenstrual syndrome: a meta analysis. British Journal of Obstetrics and Gynaecology, 111, 585-593.
44. Wyatt, K. M., Dimmock, P. W., Frischer, M., et al (2002) Prescribing patterns in premenstrual syndrome. BMC Women's Health, 2 4.
45. Yücil, B & Polat, A. (2003) Attitudes toward menstruation in premenstrual dysphoric disorder. A preliminary report in an urban Turkish population. Journal of Psychosomatic Obstetrics and Gynecology, 24, 231-237.